Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 2/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | GCGR | P47871 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30605076 | 0.87 | ABCB1 (0.39) | ABCB1HSP90AA1AHRGABRA1GABRB2 | |
| SCHEMBL28313775 | 0.79 | CA1 (0.45) | ABCB1HSP90AA1AHRGABRA1GABRB2 | |
| SCHEMBL17924597 | 0.79 | ABCB1 (0.35) | ABCB1HSP90AA1AHRGABRA1GABRB2 | |
| SCHEMBL1275011 | 0.77 | ABCB1 (0.32) | ABCB1 | |
| SCHEMBL30153212 | 0.77 | ABCB1 (0.32) | ABCB1 | |
| SCHEMBL11327097 | 0.76 | HSP90AA1 (0.39) | ABCB1HSP90AA1AHRGABRA1GABRB2 | |
| SCHEMBL28447465 | 0.75 | ABCB1 (0.35) | ABCB1HSP90AA1GABRA1GABRB1LMNA | |
| SCHEMBL22655618 | 0.75 | ABCB1 (0.35) | ABCB1HSP90AA1AHRGABRA1GABRB2 | |
| SCHEMBL28197074 | 0.74 | HSP90AA1 (0.37) | ABCB1HSP90AA1GCGR | |
| SCHEMBL17924585 | 0.73 | HPGD (0.44) | ABCB1HSP90AA1AHRGABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110359097-A | The method that On-DNA aromatic compound is obtained by Suzuki coupling reaction in the building of DNA encoding compound library | 上海药明康德新药开发有限公司 | 2019-10-22 | — | — | CN | claimed |
| CN-110331447-A | The method of On-DNA aryl acetylene hydrocarbon compound is prepared in the building of DNA encoding compound library | 上海药明康德新药开发有限公司 | 2019-10-15 | — | — | CN | claimed |
| CN-106748801-B | A kind of synthetic method of 3,5- dichloroaniline | 华东师范大学 | 2019-03-01 | — | — | CN | claimed |
| CN-108697713-A | Methods for making tricyclic PI3K inhibitor compounds and methods of treating cancer therewith | 基因泰克公司 | 2018-10-23 | — | — | CN | claimed |
| CN-102936205-B | Synthesis method of tapentadol | HEFEI XINXING PHARMACEUTICAL CHEMICAL ENGINEERING CO LTD | 2014-06-18 | — | — | CN | claimed |
| CN-118139867-A | Compound, material for organic electroluminescent element, and electronic device | 出光兴产株式会社 | 2024-06-04 | — | — | CN | disclosed |
| EP-4308570-A1 | MACROCYCLIC LRRK2 KINASE INHIBITORS | Les Laboratoires Servier (FR) | 2024-01-24 | — | — | EP | disclosed |
| CN-117377650-A | Compound, material for organic electroluminescent element, and electronic device | 出光兴产株式会社 | 2024-01-09 | — | — | CN | disclosed |
| CN-117279901-A | Compound, material for organic electroluminescent element, and electronic device | 出光兴产株式会社 | 2023-12-22 | — | — | CN | disclosed |
| WO-2023190878-A1 | TETRAHYDRONAPHTHALENE DERIVATIVE | Ａｔｒａｎｓｅｎ Ｐｈａｒｍａ株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-3943496-A1 | WEE1 INHIBITOR AND PREPARATION AND USE THEREOF | Shouyao Holdings (Beijing) Co., Ltd. (CN) | 2022-01-26 | — | — | EP | disclosed |
| EP-3894003-A1 | FUNCTIONALISED AMINE DERIVATIVES AS IL-17 MODULATORS | UCB Biopharma SRL (BE) | 2021-10-20 | — | — | EP | disclosed |
| CN-106459040-A | Heterocyclic compound | 武田药品工业株式会社 | 2017-02-22 | — | — | CN | disclosed |
| CN-103339225-B | Liquid-crystalline medium, component for high-frequency technology and mesogenic compound | 默克专利股份有限公司 | 2016-12-21 | — | — | CN | disclosed |
| CN-103384672-B | The substituted piperazine of N-pteridine and piperazine pteridinone | 武田药品工业株式会社 | 2016-09-28 | — | — | CN | disclosed |
| CN-103442568-A | Furo [3,2-d ] pyrimidine compounds | ABBVIE INC | 2013-12-11 | — | — | CN | disclosed |
| EP-2445886-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USES | Amgen, Inc (US) | 2012-05-02 | — | — | EP | disclosed |
| EP-2419428-A1 | IMIDAZO [1,2-A]PYRIDINE DERIVATIVES AS FGFR KINASE INHIBITORS FOR USE IN THERAPY | Astex Therapeutics Ltd. (GB) | 2012-02-22 | — | — | EP | disclosed |
| WO-2010151791-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USES | AMGEN INC. (US) | 2010-12-29 | — | — | WO | disclosed |
| WO-2010119285-A1 | IMIDAZO [1,2-A]PYRIDINE DERIVATIVES AS FGFR KINASE INHIBITORS FOR USE IN THERAPY | ASTEX THERAPEUTICS LIMITED (GB) | 2010-10-21 | — | — | WO | disclosed |